MSH5 Antibody

What is MSH5 and what is its primary biological function?

MSH5 is a MutS homolog protein that forms an obligate heterodimer with MSH4. Its primary function is regulating meiotic homologous recombination, playing a critical role in proper chromosome synapsis and segregation during meiosis . Recent research has also uncovered a potential role for MSH5 in immunoglobulin class switch recombination (CSR), expanding its functional significance beyond reproduction .

MSH5 is expressed at varying levels in different mouse strains, with some showing high expression (MRL/lpr (H-2k), AKR (H-2k), and BALB/c (H-2d)) and others demonstrating significantly lower expression (129/Sv (H-2b), C57BL/6 (H-2b), and FVB (H-2q)) . The difference in B cell MSH5 mRNA expression between these groups can be approximately 100-fold. In humans, MSH5 mRNA is constitutively expressed in peripheral blood B cells and Epstein-Barr virus transformed B cells, with higher expression observed in CD77+ germinal center B cells compared to naïve or memory B cells .

How does MSH5 knockout affect model organisms?

MSH5 knockout mice exhibit complete male and female sterility due to meiotic defects . When the ATPase domain of the MSH5 gene is disrupted, no normal RNA transcript encoding this domain is detected, confirming the knockout's efficacy . Importantly, MSH5 deficiency is not associated with embryonic or neonatal lethality, as intercrossing of MSH5 heterozygotes produces progeny in the expected Mendelian distribution .

What is known about MSH5's role in human immunological disorders?

Genetic variants of MSH5 have been associated with human Common Variable Immune Deficiency (CVID) and IgA Deficiency (IgAD) . Sequencing of MSH5 in 96 IgAD and CVID patients identified five nonsynonymous polymorphisms and several SNPs in noncoding regions . The L85F/P786S allele showed significant association with IgAD (P = 5.8 × 10−3) and borderline significance in CVID (P = 0.058) .

Functional studies demonstrated that the L85F/P786S MSH5 protein variant has a diminished ability to bind to MSH4 compared to wild-type MSH5, potentially explaining its association with immunodeficiency . This finding is particularly relevant as both L85F and P786S mutations are located within identified MSH4-interacting domains of MSH5 . The increased microhomology at switch junctions in patients carrying disease-associated MSH5 alleles further supports its role in class switch recombination .

What are the validated applications for MSH5 antibodies in research?

MSH5 antibodies have been successfully employed in several key research applications:

• ChIP-Seq (Chromatin Immunoprecipitation Sequencing): MSH5 antibodies have been used to characterize the dynamic binding of MSH5 during different stages of meiosis . This technique allows researchers to identify genomic regions where MSH5 binds, providing insights into its function in meiotic recombination.

• Western Blot Analysis: Polyclonal anti-MSH5 antibodies have been used to detect MSH5 protein and confirm antibody specificity by demonstrating absence of protein bands in MSH5Δ lysates .

• Immunofluorescence: MSH5 antibodies have been employed to visualize MSH5 foci on chromosomes during meiosis, revealing patterns that suggest association with both double-strand break sites on chromosomal loops and with the chromosome axis .

• Northern Blot and RT-PCR: While not directly using antibodies, these techniques complement antibody-based methods to confirm gene disruption at the transcript level .

For optimal results, researchers should validate antibodies for their specific application, as different lots of MSH5 antibodies may recognize different epitopes, resulting in varied patterns of detection .

How can researchers validate MSH5 antibody specificity?

Validating antibody specificity is crucial for obtaining reliable results in MSH5 research. Several approaches are recommended:

• Genetic Controls: Use MSH5 knockout/null samples as negative controls. As demonstrated in the research, no MSH5 protein band should be observed in MSH5Δ lysate or eluate fractions when using a specific antibody .

• Multiple Antibody Validation: When possible, use more than one antibody targeting different epitopes of MSH5. As noted in the literature, researchers have used two different rabbit anti-MSH5 antisera that could observe different kinds of MSH5 foci depending on the antibody lot .

• Recombinant Protein Controls: Test antibody binding to recombinant MSH5 protein with known concentrations.

• Immunoprecipitation Followed by Mass Spectrometry: This can confirm that the protein being pulled down is indeed MSH5.

• Cross-reactivity Testing: Evaluate potential cross-reactivity with related proteins, particularly MSH4, which forms a heterodimer with MSH5.

The research indicates that polyclonal antibodies against MSH5 generated in rabbits have been successfully used in various applications, including ChIP-Seq and immunofluorescence studies .

What are the optimal conditions for MSH5 immunoprecipitation?

Based on the research literature, successful immunoprecipitation of MSH5 has been achieved with the following conditions:

• Antibody Selection: Polyclonal rabbit anti-MSH5 antisera have been effectively used in published studies . For ChIP-Seq experiments, 5μl of MSH5 serum has been reported as an effective amount per experiment .

• Sample Preparation: For meiotic studies, careful timing of sample collection is critical as MSH5 binding is dynamic throughout meiosis. Studies have performed ChIP-Seq at multiple time points (2h to 7h at one-hour intervals) to capture this dynamic binding .

• Controls: Include appropriate negative controls such as:

  • Non-immune serum or IgG

  • MSH5-null samples where possible

  • Input samples for normalization in ChIP experiments

• Validation: Confirm the specificity of immunoprecipitation through Western blotting or mass spectrometry.

• Replication: Ensure experimental reproducibility. The cited research demonstrated high reproducibility across four replicates (r = 0.72-0.93) for MSH5 ChIP-Seq at the 5h time point .

For researchers studying MSH5 in yeast models, the protocols developed using SK1 strain of Saccharomyces cerevisiae provide a useful reference .

How do MSH5 antibodies perform in ChIP-Seq experiments?

MSH5 ChIP-Seq experiments have provided valuable insights into the protein's functions during meiosis. Key technical aspects include:

• Antibody Performance: Polyclonal rabbit anti-MSH5 antibodies have successfully identified MSH5 binding sites in ChIP-Seq experiments . The specificity of these antibodies was confirmed by the absence of MSH5 protein bands in MSH5Δ lysate or eluate fractions .

• Reproducibility: MSH5 ChIP-Seq data from four replicates at the 5h time point showed high reproducibility with correlation coefficients (r) ranging from 0.72 to 0.93 . This indicates that when properly executed, MSH5 ChIP-Seq can provide consistent and reliable results.

• Temporal Dynamics: To characterize the dynamic binding of MSH5 during different stages of meiosis, ChIP-Seq should be performed at multiple time points. The cited research conducted experiments at six time points, from 2h to 7h at one-hour intervals .

• Biological Insights: ChIP-Seq experiments have revealed that MSH5 associates with both double-strand break (DSB) sites on the chromosomal loops and with the chromosome axis to promote crossover formation .

For researchers planning MSH5 ChIP-Seq experiments, it is advisable to include appropriate controls and potentially compare results with other methods of detecting MSH5 localization, such as immunofluorescence.

What is the relationship between MSH5 and class switch recombination?

The role of MSH5 in class switch recombination (CSR) represents an emerging area of research with significant implications for immunology:

• Microhomology at Switch Junctions: MSH5-deficient mice exhibit significantly increased microhomology at immunoglobulin switch (S) junctions . Similar phenotypes were observed in both MSH5 and MSH4-null mice, suggesting a role for the MSH4/5 heterodimer in CSR .

• Antibody Isotype Deficiency: MRL/lpr mice carrying a congenic H-2b/b MHC interval (associated with low MSH5 expression) show several abnormalities regarding CSR, including a profound deficiency of IgG3 in most mice .

• Human Disease Associations: Genetic variants of MSH5 are associated with IgA deficiency and CVID in humans . The following table summarizes the relationship between MSH5 alleles and these conditions:

• Functional Impact: The L85F/P786S MSH5 protein variant shows diminished ability to bind to MSH4 compared to wild-type MSH5, potentially explaining its association with antibody deficiencies .

• Sequence Homology Relevance: The higher level of sequence homology between Sμ and Sγ3 regions than between Sμ and other S regions in mice, and between Sμ and Sα regions in humans (~70%), may explain why MSH5 has a specific role in facilitating CSR between these regions .

These findings suggest that MSH5 may play a regulatory role in CSR, potentially by influencing the choice between classical non-homologous end-joining and alternative microhomology-mediated pathways .

How does MSH5 localization change in response to meiotic double-strand breaks?

MSH5 demonstrates unique localization patterns during meiosis that provide insights into its function:

• Steady-State Focus Numbers: In wild-type yeast, the average (steady-state) number of MSH5 foci is approximately 42 . This represents the typical distribution of MSH5 on chromosomes during normal meiosis.

• Response to DSB Reduction: Interestingly, MSH5 focus numbers are maintained even when meiotic double-strand breaks (DSBs) are reduced . This suggests a homeostatic mechanism that regulates MSH5 localization independently of the absolute number of DSBs.

• Association with Chromosomal Structures: Research suggests that MSH5 associates with both DSB sites on the chromosomal loops and with the chromosome axis to promote crossover formation . This dual localization pattern may explain how MSH5 contributes to proper meiotic recombination.

• Antibody-Dependent Detection: Different lots of MSH5 antibodies can detect different kinds of MSH5 foci . In one study, researchers used an antibody that recognizes brighter foci specifically, which resulted in fewer observed foci than in previous reports . This highlights the importance of antibody selection when studying MSH5 localization.

• Dynamic Binding During Meiosis: ChIP-Seq experiments performed at multiple time points (from 2h to 7h at one-hour intervals) have revealed that MSH5 binding to chromosomes changes throughout meiosis . This temporal dynamics likely reflects the protein's varying roles during different stages of the meiotic process.

Understanding MSH5's localization patterns and how they respond to changes in meiotic conditions provides valuable insights into its function in ensuring proper chromosome synapsis and recombination.

How can researchers optimize immunofluorescence detection of MSH5 foci?

Detecting MSH5 foci through immunofluorescence requires careful optimization:

• Antibody Selection: Different lots of anti-MSH5 antisera can detect different kinds of MSH5 foci . Some antibodies may recognize brighter foci specifically, resulting in fewer observed foci than expected . It is advisable to test multiple antibody lots or sources when establishing a new immunofluorescence protocol.

• Fixation Methods: While specific fixation methods for MSH5 are not detailed in the provided materials, standard protocols for meiotic chromosome preparations typically involve:

  • Paraformaldehyde fixation (typically 1-4%)

  • Permeabilization with detergents like Triton X-100

  • Careful temperature control during fixation and washing steps

• Controls and Co-localization: Include appropriate controls:

  • MSH5-null samples as negative controls

  • Co-staining with other proteins known to interact with MSH5 (e.g., MSH4)

  • Co-staining with markers of specific chromosomal structures (e.g., Zip1 for the synaptonemal complex)

• Quantification Methods: For accurate counting of MSH5 foci, researchers should:

  • Establish consistent criteria for foci identification

  • Use appropriate image analysis software

  • Apply consistent thresholding across samples

  • Consider 3D imaging to capture foci at different focal planes

• Stage-Specific Analysis: Since MSH5 localization changes throughout meiosis, carefully stage your cells based on established markers (such as synaptonemal complex formation) to ensure comparable observations across samples.

In yeast studies, researchers have successfully used antibodies specific for Zip1, Zip3, Mer3, Spo22, MSH5, Dmc1, and Rad51 for co-localization experiments . These can serve as useful markers for different meiotic structures and events.

What are common pitfalls in MSH5 antibody-based experiments?

Several challenges can arise when working with MSH5 antibodies:

• Antibody Lot Variation: Different lots of MSH5 antibodies may recognize different epitopes or have varying affinities, leading to inconsistent results . Always validate new antibody lots against previous ones before conducting critical experiments.

• Expression Level Variations: MSH5 expression levels vary dramatically across different strains and genetic backgrounds. For instance, some mouse strains show approximately 100-fold differences in B cell MSH5 mRNA expression levels . These variations must be considered when interpreting results across different genetic backgrounds.

• False Negatives in Knockout Validation: When validating MSH5 knockouts, be aware that residual transcripts of upstream and downstream sequences may be present despite disruption of the coding region . Complete validation should involve multiple approaches including protein detection.

• Dynamic Expression During Cell Cycles: MSH5 expression and localization change during meiosis, making the timing of sample collection critical. In some contexts, MSH5 is inducible in B cells from certain mouse strains but not others .

• Potential Cross-Reactivity: Given that MSH5 forms a heterodimer with MSH4 and shares homology with other MutS family proteins, antibodies may cross-react with related proteins. Thorough specificity testing is essential.

• Genetic Background Effects: The phenotypic effects of MSH5 deficiency can be influenced by genetic background. For example, antibody deficiency was observed in congenic MRL/lpr mice but not in inbred strains carrying hypomorphic alleles of MSH5 (e.g., C57BL/6, 129/Sv) .

To mitigate these issues, researchers should:

• Use multiple detection methods when possible

• Include appropriate genetic controls

• Be consistent with experimental timing

• Validate antibodies thoroughly before use

• Consider genetic background effects when interpreting results

How should researchers interpret varying numbers of MSH5 foci across studies?

The reported number of MSH5 foci can vary significantly between studies. Researchers should consider several factors when interpreting these variations:

• Antibody Specificity: Different anti-MSH5 antibodies may recognize different epitopes or populations of MSH5. As noted in one study, researchers observed fewer MSH5 foci than in previous reports because they used an antibody that specifically recognizes brighter foci .

• Biological Variation: The number of MSH5 foci may naturally vary among:

  • Different organisms (yeast vs. mouse vs. human)

  • Different genetic backgrounds

  • Different stages of meiosis

  • Different cell types (germline vs. B cells)

• Technical Variations: Differences in:

  • Fixation methods

  • Imaging techniques (conventional vs. super-resolution microscopy)

  • Detection thresholds

  • Sample preparation

• Functional Interpretations: Rather than focusing solely on absolute numbers, consider what the pattern of foci reveals about MSH5 function. For example, the maintenance of MSH5 focus numbers even when double-strand breaks are reduced suggests a homeostatic localization mechanism .

• Temporal Dynamics: MSH5 binding to chromosomes changes throughout meiosis . Studies that examine different time points may report different numbers of foci.

When comparing MSH5 foci counts across studies, researchers should carefully evaluate methodological differences and consider whether the differences in foci numbers reflect biological reality or technical variation.

What are emerging applications of MSH5 antibodies in disease research?

MSH5 antibodies are becoming increasingly valuable for investigating several disease contexts:

• Reproductive Disorders: Given MSH5's critical role in meiosis, antibodies can help investigate causes of infertility, particularly those involving recombination defects. MSH5 knockout mice exhibit complete male and female sterility due to meiotic defects , making it a relevant target for human fertility studies.

• Immunodeficiency Disorders: The association between MSH5 variants and antibody deficiencies (IgAD and CVID) opens new avenues for research . MSH5 antibodies could help characterize B cell abnormalities in patients carrying disease-associated MSH5 alleles.

• Cancer Biology: As a DNA repair and recombination protein, MSH5 may play roles in genome stability relevant to cancer. Antibodies could help investigate potential alterations in MSH5 expression or localization in cancer cells.

• Autoimmune Diseases: The involvement of MSH5 in antibody diversification suggests potential roles in autoimmune pathologies. Investigating MSH5 in models of autoimmunity could yield new insights.

• Fundamental B Cell Biology: MSH5 antibodies can help elucidate the protein's unexpected role in class switch recombination, particularly the choice between classical non-homologous end-joining and alternative microhomology-mediated pathways .

Future research might leverage emerging technologies such as mass cytometry, single-cell analysis, and super-resolution microscopy in conjunction with MSH5 antibodies to gain deeper insights into these disease processes.

How might single-cell techniques enhance MSH5 research?

Single-cell techniques offer promising opportunities to advance MSH5 research:

• Heterogeneity Analysis: Single-cell approaches can reveal cell-to-cell variations in MSH5 expression and localization that might be masked in bulk analyses. This is particularly relevant for studying meiotic cells, which progress asynchronously through different stages.

• Combinatorial Protein Analysis: Single-cell proteomics or mass cytometry (CyTOF) with MSH5 antibodies could reveal how MSH5 expression correlates with other proteins across individual cells, potentially identifying new functional relationships.

• Spatial Context: Emerging spatial transcriptomics and proteomics techniques could provide insights into where MSH5 is expressed within tissues, which might be particularly valuable for studying its role in germinal centers during immune responses.

• Temporal Dynamics: Single-cell time-course experiments could provide finer resolution of how MSH5 function changes throughout meiosis or during B cell activation.

• Genetic Background Effects: Single-cell approaches combined with genetic analysis could help explain why MSH5 deficiency has variable phenotypic effects across different genetic backgrounds .

These approaches could help resolve contradictions in existing literature, such as why MSH5 focus numbers are maintained even when double-strand breaks are reduced , or why antibody deficiency is observed in some genetic backgrounds but not others .